Gastric cancer causes severe pulmonary hypertension that improves rapidly with imatinib

This gastric cancer diagnosis at a glance

Stage at diagnosis
Stage IV
Subtype
Adenocarcinoma
Sex
Female
Treatment
targeted therapy and chemotherapy
Outcome
In Memory

Treatment course, step by step

  1. Received imatinib for pulmonary tumor thrombotic microangiopathy, with rapid improvement in pulmonary hypertension.
  2. After discharge, received gastric cancer chemotherapy that included oxaliplatin.

What happened, in summary

A 56-year-old woman developed leg swelling and worsening shortness of breath over 2 months. Testing showed severe pulmonary hypertension, but CT did not show a conventional blood clot or a visible lung tumor. Enlarged para-aortic lymph nodes prompted early gastrointestinal evaluation, and endoscopy found gastric cancer. Biopsy showed poorly differentiated gastric adenocarcinoma with signet-ring cells.

Her breathing and circulation deteriorated rapidly, and the clinical picture was considered pulmonary tumor thrombotic microangiopathy, a rare complication in which cancer cells affect the small blood vessels of the lungs. Oxygen, dobutamine and bosentan did not improve her pulmonary pressures. She then received off-label imatinib. Within 5 days, her pulmonary artery pressure normalized and her shortness of breath resolved.

She was discharged and continued gastric cancer chemotherapy that included oxaliplatin. The pulmonary hypertension did not recur. Despite that improvement, the gastric cancer later spread systemically, and she died 7 months after the pulmonary vascular presentation.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar gastric cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more gastric cancer stories